State of Insurtech Q2’24 Report
Insurtech funding sees its strongest quarter in over a year despite deal volume sinking to its lowest point since 2016.
Insurtech funding sees its strongest quarter in over a year despite deal volume sinking to its lowest point since 2016.
From medical scribes to clinical trial platforms, AI-driven solutions are key targets of digital health M&A deals in 2024 so far. Here’s where we’re seeing the most activity.
Our expert explains how AI agents are tackling enterprise workflows across industries and the key trends to watch.
$100M+ mega-rounds drive growth in corporate venture capital-backed funding in Q2’24, while deal activity falters.
AI funding hits $23.2B in Q2’24 — the highest quarterly level on record.
In-Q-Tel’s investment activity has implications for the private and public sectors. We mined its bets since Q2’22 to uncover the technologies it’s prioritizing, from biological computing to AI security.
As concerns mount around the rise of counterfeit drugs, supply chain technologies such as IoT asset tracking, blockchain ledgers, and product & packaging authentication can provide pharma companies with more visibility and supply chain security.
We explore how insurers are using genAI to improve customer experience, employee productivity, and underwriting.
Funding in digital health drops, but larger check sizes and an uptick in exits highlight bright spots for the industry in Q2’24.
Assess how prepared US health systems are to adopt and respond to rapidly evolving AI technologies.
Midway through 2024, AI startups continue to steal the show. Now, our expert is diving into the trends shaping the space.
AI startups steal the show, grabbing over a third of all funding, while the rest of the venture ecosystem remains tepid in Q2’24.
We mined Sanofi's investments and partnerships to discern the company’s strategic priorities.
In this webinar, our expert digs into where funding is going, trends in deal activity, and which sectors are seeing the most (and least) momentum.
Tech leaders are aggressively applying cloud computing and generative AI to tackle issues in healthcare. We look at how 4 tech giants are building their positions in the industry using strategic investments, partnerships, and product launches.
We mined Nationwide’s investments and partnerships to discern the company’s strategic priorities.
We mined the CB Insights database to map 433 startups across 60 different categories, from protein design to ML security.
This report uses the CB Insights TECH Framework to rank femtech markets based on current commercial readiness and momentum.
As we approach the midpoint of the year and look towards 2025, our experts share the disruptive tech markets and trends they’re tracking across industries.
AI funding hits a 4-quarter high — fueled by massive genAI rounds — while deals continue to fall in Q1’24.
From commercializing quantum computer applications in industries like finance and healthcare to defending against quantum algorithms with new post-quantum cryptography standards, the quantum information landscape is rapidly becoming more complex. We break down the tech companies defining the quantum future.
We mined earnings calls, analyzed business relationships, and dug into investments and acquisitions to survey the AI activities of some of the world’s largest companies across industries.
We mined Google’s investments and partnerships to discern the company's strategic priorities in healthcare.
While digital health funding rebounds in Q1'24, deal count hits a multi-year low.
Discover what global leaders in pharma, financial services, industrials, and enterprise tech are doing in AI – and what it means for the future of each sector.